Question of the Day – Thursday October 5, 2017
Question: What is the active chemical component in nutmeg and what are the toxicological effects associated with this this compound?
Question of the Day – Monday October 2, 2017
Question: What is the immunological basis for the development of food allergy-associated anaphylaxis?
Question of the Day -Tuesday October 3, 2017
Question: What characterized the so-called “phossy jaw” epidemic of the late 1800’s/early 1900’s
Question of the Day – Friday September 29, 2017
Question: What are the contraindications and relative contraindications to intranasal naloxone administration?
Question of the Day – Thursday September 28, 2017
Question: What are the pharmacological risks for the development of Clostrdium difficile infection (CDI)?
Question of the Day – Wednesday September 27, 2017
Question: Q fever is a CDC Category B terrorism threat agent because it is are moderately easy to disseminate; may result in moderate morbidity rates and low mortality rates; and requires specific enhancements of CDC’s diagnostic capacity and enhanced disease surveillance. What is the source for this infection in most cases?
Question of the Day – Tuesday September 26, 2017
Question: Which form of anthrax has the highest case fatality rate?
Question: Which form of anthrax has the highest case fatality rate?
Question of the Day – Monday September 25, 2017
Question: B. anthracis, the causative organism for anthrax, has three major virulence factors; an antiphagocytic capsule and two exotoxins. What are the two exotoxins?
Question of the Day Friday September 22, 2017
Question: The clinical triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal injury characterizes the hemolytic uremic syndrome (HUS). HUS is the leading cause for acute kidney injury in the pediatric population. The majority of HUS cases develop following a gastrointestinal infection with Escherichia coli O157. Which toxin, produced by this bacterium, is the putative toxin in the development of HUS?
